Back to 
Walleye Capital LLC
Walleye Capital LLC
XERS
Showing 0 of 2 quarters
Position history for Walleye Capital LLC's holdings in XERIS PHARMACEUTICALS INC
No. Walleye Capital exited its XERS (Xeris Pharmaceuticals) position in Q2 2020. Its Q1 2020 13F listed 113,269 shares worth $221,000. Walleye Capital first reported XERS in Q1 2020 and held it in 1 quarterly 13F filing.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.